Get the Stockscreener App
2.34
15.84%
0.32
After Hours:
2.25
-0.09
-3.85%
Cibus Inc stock is traded at $2.34, with a volume of 546.65K.
It is up +15.84% in the last 24 hours and up +42.68% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$2.02
Open:
$2.02
24h Volume:
546.65K
Relative Volume:
1.48
Market Cap:
$123.34M
Revenue:
$1.82M
Net Income/Loss:
$-267.63M
P/E Ratio:
-0.116
EPS:
-20.1639
Net Cash Flow:
$-50.53M
1W Performance:
+38.46%
1M Performance:
+42.68%
6M Performance:
+50.97%
1Y Performance:
-21.48%
1-Day Range:
$1.9749
$2.415
1-Week Range:
$1.6469
$2.415
52-Week Range:
$1.09
$3.40
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
2.34 | 106.47M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Cibus repurchases shares from employee in board-approved transaction By Investing.com - Investing.com Australia
Cibus repurchases shares from employee in board-approved transaction - Investing.com
Cibus executes minor internal Class A share repurchase - TipRanks
Cibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin America - AgriBusiness Global
Retail Trends: Why Cibus Inc stock is a must watch in 2025Weekly Market Outlook & Daily Profit Maximizing Tips - moha.gov.vn
Cibus and Interoc sign LOI for herbicide-tolerant rice in Latin America By Investing.com - Investing.com South Africa
Cibus, Inc. (NASDAQ:CBUS) surges 15%; individual investors who own 43% shares profited along with insiders - Yahoo Finance
Cibus (CBUS) and Interoc Plan Commercialization of Herbicide-Tol - GuruFocus
Cibus and Interoc sign LOI for herbicide-tolerant rice in Latin America - Investing.com India
Cibus and Interoc Advance Rice Commercialization Strategy - GlobeNewswire
Retail investors invested in Cibus, Inc. (NASDAQ:CBUS) up 11% last week, insiders too were rewarded - simplywall.st
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), UCB SA (GB:0NZT) and Cibus (CBUS) - The Globe and Mail
Cibus director Prante Gerhard sells $2,875 in stock - MSN
Short Interest in Cibus, Inc. (NASDAQ:CBUS) Decreases By 32.9% - MarketBeat
Stock Market Recap: Why Cibus Inc stock is a must watch in 20252025 Volatility Report & Verified Short-Term Plans - moha.gov.vn
Aug Ideas: Is Cibus Inc. stock attractive for long term wealth buildingJuly 2025 Spike Watch & Low Volatility Stock Suggestions - Улправда
Will Cibus Inc. stock pay special dividendsWeekly Profit Summary & Long-Term Capital Growth Ideas - Улправда
Cibus (CBUS) EV-to-OCF : -1.87 (As of Dec. 19, 2025) - GuruFocus
How Cibus Inc. stock responds to policy changesJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - Улправда
Craig Wichner Net Worth (2025) - GuruFocus
Will Cibus Inc. stock attract more institutional investorsEarnings Beat & Short-Term Trading Alerts - bolumsonucanavari.com
Guidance Update: Is Cibus Inc. stock recession proof2025 Trade Ideas & High Conviction Buy Zone Picks - Улправда
Is Cibus Inc. stock recession proof2025 Bull vs Bear & Weekly Market Pulse Alerts - Улправда
Gratia Capital LLC Acquires New Shares in Cibus, Inc. $CBUS - MarketBeat
Cibus director Prante sells $2,875 in stock - MSN
Signal Recap: Can Cibus Inc stock maintain growth trajectory2025 Macro Impact & Weekly Return Optimization Alerts - moha.gov.vn
CBUS FinancialsIncome Statement - Quiver Quantitative
Cibus (CBUS) Applauds EU Agreement on Gene-Edited Plant Regulati - GuruFocus
Cibus Welcomes EU Political Agreement on New Genomic Techniques, Supporting Advances in Plant Breeding Innovation - Quiver Quantitative
Cibus (Nasdaq: CBUS) sees EU NGT agreement advancing gene-edited plant rules - Stock Titan
Canaccord Genuity Remains a Buy on Cibus (CBUS) - The Globe and Mail
Cibus’ (CBUS) “Buy” Rating Reaffirmed at Canaccord Genuity Group - Defense World
Is Cibus Stock Built to Withstand a Pullback? - Trefis
Canaccord Genuity Maintains Cibus (CBUS) Buy Recommendation - Nasdaq
Cibus (CBUS) Stock Rating Maintained at "Buy" by Canaccord Genui - GuruFocus
Cibus (NASDAQ:CBUS) Earns "Buy" Rating from Canaccord Genuity Group - MarketBeat
ETFs Investing in Cibus, Inc. Stocks - TradingView — Track All Markets
What drives Cibus Inc stock priceStock Valuation Metrics & Free High Frequency Trading Ideas - earlytimes.in
Cibus (CBUS) Total Equity : $52.03 Mil (As of Sep. 2025) - GuruFocus
Cibus (NASDAQ:CBUS) and Brasilagro Cia Brasileira De Propriedades Agricolas (NYSE:LND) Critical Review - Defense World
Insider Sell: How Cibus Inc. stock responds to policy changesJuly 2025 Sector Moves & Precise Trade Entry Recommendations - moha.gov.vn
Cibus director Gerhard Prante sells $2,817 in stock - MSN
Cibus CBUS grants director 45,627 options expiring in 2035 - Stock Titan
[Form 3] Cibus, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Cibus (CBUS) Other Stockholders Equity : $0.00 Mil (As of Sep. 2025) - GuruFocus
Cibus, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
What is the fair value of Cibus Inc. stock nowMarket Risk Report & Reliable Trade Execution Plans - newser.com
Is Cibus Inc. stock overvalued by current metricsPrice Action & AI Driven Stock Movement Reports - newser.com
Sidoti Csr Weighs in on Cibus' FY2025 Earnings (NASDAQ:CBUS) - MarketBeat
Cibus (CBUS) EBIT per Share : $-2.55 (TTM As of Sep. 2025) - GuruFocus
Will Cibus Inc. stock continue upward momentumWeekly Profit Report & Fast Gaining Stock Reports - newser.com
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):